Very good analogy , a stronger strategic description of the commercial opportunity is required and within a given time frame.
LCT have been reactive to results , plenty of Highly Qualified Scientists on board but the business of LCT seems to be wanting.
Opportunity here as there always has been ,, if LCT can deliver positive results and they gain regulatory permission to continue with commercial testing, The Company still have to outline a business model , (what is the Price Point for Treatment? will it be in New Zealand? How many Treatments could be carried out per Quarter, ) would make a great licensing model with LCT controlling the NTCELL manufacturing.
Dubai would make a brilliant hub , plenty of flights and infrastructure? Obviously a USA based Private Hospital ,possibly a Swedish European Clinic?
Best of Luck
Very good analogy , a stronger strategic description of the...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $12.51K | 1.772M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 8514050 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1913304 | 15 |
View Market Depth
| Last trade - 15.29pm 11/09/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |